New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni

Current protocols in immunology

Roald Nezlin · Molecular Immunology · 1992 · 1.4K citations

Vaccination, Laboratory Immunology, Immunology +6

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

Marieke J. van der Werf, Sake J. de Vlas, Simon Brooker et al. · Acta Tropica · 2003 · 948 citations

Parasitic Disease, Epidemiology, Clinical Morbidity +11

Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

Angela N Kuntz, Elisabeth Davioud–Charvet, Ahmed A. Sayed et al. · PLoS Medicine · 2007 · 359 citations · Full text

Identification of oxadiazoles as new drug leads for the control of schistosomiasis

Ahmed A. Sayed, Anton Simeonov, Craig J. Thomas et al. · Nature Medicine · 2008 · 269 citations · Full text

New Drug, Medicinal Chemistry, Antiparasitic Agent +11

Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans

Martin Feelisch, Karl Schönafingeri, Hike Noack · Biochemical Pharmacology · 1992 · 161 citations

Thiol-mediated Generation, Biochemistry, Reactive Nitrogen Specie +10